Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis

Brain

Volumn 132, Issue 1, 2009, Pages 260-273

  Lonigro, Aurélie ^a   Devaux, Jérôme J ^a  

^a University of Mediterranée   (France)

Author keywords

AIDP; GBS; Multiple sclerosis; Paranode; Sodium channels

Indexed keywords

AUTOANTIBODY; CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C5B; GLIOMEDIN; MYELIN; NEUROFASCIN; PROTEIN P2; SHAKER POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ALLERGIC NEUROPATHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DISRUPTION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DEGRADATION KINETICS; DEMYELINATION; GLIA CELL; LEWIS RAT; MALE; NERVE CONDUCTION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; RANVIER NODE; RAT; SCHWANN CELL; SYNAPSE; VENTRAL ROOT;

EID: 58849149363     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn281     Document Type: Article

References (57)

1. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985; 8: 528-39.
2. Allen D, Giannopoulos K, Gray I, Gregson N, Makowska A, Pritchard J, et al. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2005; 10: 174-80.
3. Arroyo EJ, Sirkowski EE, Chitale R, Scherer SS. Acute demyelination disrupts the molecular organization of peripheral nervous system nodes. J Comp Neurol 2004; 479: 424-34.
4. Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, et al. Axon-glia interactions and the domain organization of myelinated axons requires Neurexin IV/Caspr/Paranodin. Neuron 2001; 30: 369-83.
5. Bouzidi M, Tricaud N, Giraud P, Kordeli E, Caillol G, Deleuze C, et al. Interaction of the Nav1.2a subunit of the voltage-dependent sodium channel with nodal Ankyrin(G) - in vitro mapping of the interacting domains and association in synaptosomes. J Biol Chem 2002; 277: 28996-9004.
6. Boyle MET, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 2001; 30: 385-97.
7. Charles P, Tait S, Faivre-Sarrailh C, Barbin G, Gunn-Moore F, Denisenko-Nehrbass N, et al. Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction. Curr Biol 2002; 12: 217-20.
8. Cooper EC, Harrington E, Jan YN, Jan LY. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci 2001; 21: 9529-40.
9. Davis JQ, Lambert S, Bennett V. Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin + third FNIII domain-) and NrCAM at nodal axon segments. J Cell Biol 1996; 135: 1355-67.
10. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. KCNQ2 is a nodal K + channel. J Neurosci 2004; 24: 1236-44.
11. Devaux JJ, Scherer SS. Altered ion channels in an animal model of Charcot-Marie-Tooth disease type IA. J Neurosci 2005; 25: 1470-80.
12. Dupree JL, Girault JA, Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J Cell Biol 1999; 147: 1145-51.
13. Einheber S, Zanazzi G, Ching W, Scherer SS, Milner TA, Peles E, et al. The axonal membrane protein Caspr/Neurexin IV is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 1997; 139: 1495-506.
14. Eshed Y, Feinberg K, Carey DJ, Peles E. Secreted gliomedin is a perinodal matrix component of peripheral nerves. J Cell Biol 2007; 177: 551-62.
15. Eshed Y, Feinberg K, Poliak S, Sabanay H, SarigNadir O, Spiegel I, et al. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron 2005; 47: 215-29.
16. Fujioka T, Purev E, Kremlev SG, Ventura ES, Rostami A. Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis. J Neuroimmunol 2000; 108: 181-91.
17. Gabriel CM, Gregson NA, Hughes RA. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 2000; 104: 139-46.
18. Gabriel CM, Gregson NA, Redford EJ, Davies M, Smith KJ, Hughes RA. Human immunoglobulin ameliorates rat experimental autoimmune neuritis. Brain 1997; 120 (Pt 9): 1533-40.
19. Hafer-Macko C, Hsieh ST, Li CY, Ho TW, Sheikh K, Cornblath DR, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 1996a; 40: 635-44.
20. Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996b; 39: 627-37.
21. Hahn AF, Feasby TE, Steele A, Lovgren DS, Berry J. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage. Lab Invest 1988; 59: 115-25.
22. Hahn AF, Feasby TE, Wilkie L, Lovgren D. P2-peptide induced experimental allergic neuritis - a model to study axonal degeneration. Acta Neuropathol 1991; 82: 60-5.
23. Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barre syndrome. Neurology 2005; 64: 856-60.
24. Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, et al. Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 2006; 129: 3173-85.
25. Hughes PM, Wells GM, Clements JM, Gearing AJ, Redford EJ, Davies M, et al. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 1998; 121 (Pt 3): 481-94.
26. Hughes R, Atkinson P, Coates P, Hall S, Leibowitz S. Sural nerve biopsies in Guillain-Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992; 15: 568-75.
27. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 1999; 100: 74-97.
28. Jenkins SM, Bennett V. Developing nodes of Ranvier are defined by ankyrin-G clustering and are independent of paranodal axoglial adhesion. Proc Natl Acad Sci USA 2002; 99: 2303-8.
29. Kadlubowski M, Hughes RA. Identification of the neuritogen for experimental allergic neuritis. Nature 1979; 277: 140-1.
30. Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barre syndromes. Ann Neurol 2002; 52: 180-7.
31. Kwa MSG, vanSchaik IN, Brand A, Baas F, Vermeulen M. Investigation of serum response to PMP22, connexin 32 and P-0 in inflammatory neuropathies. J Neuroimmunol 2001; 116: 220-5.
32. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
33. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007; 204: 2363-72.
34. Menegoz M, Gaspar P, Le Bert M, Galvez T, Burgaya F, Palfrey C, et al. Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 1997; 19: 319-31.
35. Mi HY, Deerinck TJ, Ellisman MH, Schwarz TL. Differential distribution of closely related potassium channels in rat Schwann cells. J. Neurosci. 1995; 15: 3761-74.
36. Norton WT, Poduslo SE. Myelination in rat brain. Method of myelin isolation. J Neurochem 1973; 21: 749-58.
37. Novakovic SD, Levinson R, Schachner M, Shrager P. Disruption and reorganization of sodium channels in experimental allergic neuritis. Muscle Nerve 1998; 21: 1019-32.
38. Occhi S, Zambroni D, DelCarro U, Amadio S, Sirkowski EE, Scherer SS, et al. Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci 2005; 25: 9418-27.
39. OHanlon GM, Humphreys PD, Goldman RS, Halstead SK, Bullens RWM, Plomp JJ, et al. Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. Brain 2003; 126: 2497-509.
40. Olee T, Powell HC, Brostoff SW. New minimum length requirement for a T cell epitope for experimental allergic neuritis. J Neuroimmunol 1990; 27: 187-90.
41. Pan ZM, Kao TC, Horvath Z, Lemos J, Sul JY, Cranstoun SD, et al. A common ankyrin-G-based mechanism retains KCNQ and Na-V channels at electrically active domains of the axon. J Neurosci 2006; 26: 2599-613.
42. Paparounas K, O'Hanlon GM, O'Leary CP, Rowan EG, Willison HJ. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. Brain 1999; 122 (Pt 5): 807-16.
43. Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre Syndrome. J Neurol Sci 2000; 174: 16-21.
44. Ren Q, Bennett V. Palmitoylation of neurofascin at a site in the membrane-spanning domain highly conserved among the L1 family of cell adhesion molecules. J Neurochem 1998; 70: 1839-49.
45. Rios JC, MelandezVasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, et al. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J Neurosci 2000; 20: 8354-64.
46. Robinson WH, Fontoura P, Lee BJ, de Vegvar HE, Tom J, Pedotti R, et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 2003; 21: 1033-9.
47. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996; 19: 474-87.
48. Sherman DL, Tait S, Melrose S, Johnson R, Zonta B, Court FA, et al. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron 2005; 48: 737-42.
49. Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 2007; 299: 1-8.
50. Southwood C, He C, Garbern J, Kamholz J, Arroyo E, Gow A. CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure. J Neurosci 2004; 24: 11215-25.
51. Stoll G, Schmidt B, Jander S, Toyka KV, Hartung HP. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991; 30: 147-55.
52. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 2007; 27: 3956-67.
53. Tait S, Gunn-Moore F, Collinson JM, Huang J, Lubetzki C, Pedraza L, et al. An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol 2000; 150: 657-66.
54. Uyemura K, Suzuki M, Kitamura K, Horie K, Ogawa Y, Matsuyama H, et al. Neuritogenic determinant of bovine P2 protein in peripheral nerve myelin. J Neurochem 1982; 39: 895-8.
55. Yuki N, Koga M. Bacterial infections in Guillain-Barre and Fisher syndromes. Curr Opin Neurol 2006; 19: 451-7.
56. Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 1994; 125: 132-7.
57. Zonta B, Tait S, Melrose S, Anderson H, Harroch S, Higginson J, et al. Glial and neuronal isoforms of Neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system. J Cell Biol 2008; 181: 1169-77.